ProCE Banner Events

Individualized Treatment Decisions for Your Patients in AML First Remission

Expert faculty will discuss the importance of treatment after first AML remission, review the latest data for a treatment option, and discuss shared decision making through a real patient story.

This event has expired. No longer available for credits.

Time and location

Tuesday, October 29, 2024

12:15 PM - 1:00 PM Eastern Time (ET)

Virtual

Faculty
Thomas William LeBlanc, MD, MA, MHS, FAAHPM, FASCO

Associate Professor of Medicine
Chief Patient Experience and Safety Officer for the Duke Cancer Institute
Director of Outcomes Research in Division of Hematologic Malignancies and Cellular Therapy
Duke University School of Medicine
Duke Cancer Institute
Durham, North Carolina

Sponsored By

ProCE Banner

2011-US-2400177_0924